Terumo Provides Update on Impact from Hurricane Maria
- Oct 10, 2017
TOKYO, JAPAN – October 10, 2017 – Terumo Corporation (TSE: 4543) today provided an update on the impact to its manufacturing as a result of Hurricane Maria.
In the aftermath of Hurricane Maria, Terumo has been working diligently to assess the impact to its operations in Caguas, Puerto Rico, where Terumo manufactures the Angio-Seal™ Vascular Closure product line. The safety of 261 Terumo associates and their families located on the island remains Terumo’s top priority. As of October 6, Terumo has accounted for 100% of the associates. Terumo’s outreach to them is ongoing and Terumo is providing relief assistance to them.
Terumo has been suspending its manufacturing since September 20. The facility sustained minimal structural damage and Terumo is in the process of making repairs. Terumo is doing everything possible to return to normal operations and provide the Angio-Seal™ family of products to its customers and patients.
The impact of the disaster on Terumo's business performance is being examined. Further details regarding the impact will be disclosed, as needed, once the analysis is completed.
About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.